Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$344,444
+$276,445 QoQ
Shares Held
27,272
+532.5% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. ENTA ranks #221 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in ENTA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $344,444 | 27,272 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $67,999 | 4,312 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,365 | 1,785 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,539 | 1,791 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,632 | 6,274 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $446,107 | 77,584 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $510,757 | 49,301 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $537,762 | 41,462 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $688,290 | 39,421 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $288,557 | 30,665 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $389,375 | 34,859 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,001,521 | 140,258 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,856,884 | 120,101 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $12,315,844 | 264,743 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,115,749 | 310,695 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $16,560,240 | 350,333 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,237,802 | 242,172 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $897 | 12 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $681 | 12 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $528 | 12 | Shares | Defined | 2021-08-13 | |
| 2020-06-30 | $2,711 | 54 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $627,188 | 12,195 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||